Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Antiparasite therapy].

Pilar Aparicio1, Esperanza Rodríguez, Teresa Gárate

  • 1Centro Nacional de Medicina Tropical. Instituto de Salud Carlos III. Madrid. Spain.

Enfermedades Infecciosas Y Microbiologia Clinica
|December 4, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Are mosquito species present in Spain competent for Oropouche virus?

Parasites & vectors·2026
Same author

Revisiting the largest human leishmaniasis outbreak in Western Europe (Madrid, Spain): a follow-up entomological study in 2023 and 2024.

Parasites & vectors·2026
Same author

Elimination of visceral leishmaniasis as a public health problem in Bangladesh: Lessons learned and questions remaining.

PLoS neglected tropical diseases·2026
Same author

Ten-year population-based assessment of multimorbidity burden progression in a regional cohort of 5.5 million adults.

NPJ digital medicine·2026
Same author

Synergistic Effects of Non-Thermal Plasma Exposure Time and Drought on Alfalfa (<i>Medicago sativa</i> L.) Germination, Growth and Biochemical Responses.

International journal of molecular sciences·2026
Same author

The development of a global research agenda and individual participant data platform for visceral leishmaniasis: challenges and future opportunities.

Parasites & vectors·2025
Same journal

New COVID-19 vaccination recommendations in Spain: Optimizing for next seasons.

Enfermedades infecciosas y microbiologia clinica·2025
Same journal

[Description of 12 HIV-positive patients who have had the COVID-19 in our area].

Enfermedades infecciosas y microbiologia clinica·2024
Same journal

[SARS-CoV-2 infection as trigger multisystem inflammatory syndrome?]

Enfermedades infecciosas y microbiologia clinica·2024
Same journal

Impact of COVID-19 on Madrid hospital system.

Enfermedades infecciosas y microbiologia clinica·2024
Same journal

[COVID-19 and influenza A coinfection: a matter of principle].

Enfermedades infecciosas y microbiologia clinica·2024
Same journal

COVID and CARE®. Mobile application for monitoring SARS-CoV-2 positive patients after hospitalization.

Enfermedades infecciosas y microbiologia clinica·2024
See all related articles

Preventing parasitic diseases relies on environmental health and vector control, as no vaccines exist. New anti-parasite drugs are developed through screening and understanding parasite physiology for better treatment options.

Area of Science:

  • Parasitology
  • Pharmacology
  • Drug Discovery

Context:

  • Parasitic diseases lack vaccines, necessitating reliance on ecological control and antiparasitic drugs for prevention and treatment.
  • Current drug development often employs screening of existing molecules rather than solely relying on parasite biochemistry.
  • Understanding drug mechanisms of action is crucial for advancing parasite physiology knowledge.

Purpose:

  • To review current strategies for parasitic disease prevention and treatment.
  • To explore the role of drug screening and parasite biochemistry in developing new antiparasitic agents.
  • To discuss rational drug design approaches based on known antiparasitic drug mechanisms.

Summary:

  • Prevention of parasitic diseases hinges on environmental health and vector control due to the absence of vaccines.

Related Experiment Videos

  • Antiparasitic drugs are essential for treatment after infection, with ongoing research into their mechanisms of action.
  • While intelligent screening of generic molecules has yielded many drugs, understanding parasite biochemistry is key for future rational drug design.

    • Impact:

    • Highlights the need for novel vaccine development against parasitic infections.
    • Emphasizes the importance of continued research into antiparasitic drug mechanisms and discovery.
    • Provides insights into rational drug design strategies for combating parasitic diseases effectively.